Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GL-SRF-003 is a microbiome-based therapeutic candidate being developed by GI Longevity, a subsidiary of GI Biome. It is currently in the early stages of development for the treatment of various hair conditions. The therapy likely utilizes specific microbial strains or consortia to modulate the gut-hair axis or local scalp environment, though the exact mechanism of action and specific microbial components have not been publicly disclosed. It is categorized within the company's therapeutic pipeline, distinguishing it from their functional food products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GL-SRF-003.